Opinion
Video
The Role for Systematic Biopsy Plus MRI-Targeted Procedures
Author(s):
Focusing on the role of systematic biopsy, the panel provides clinical insights on biopsy practice patterns after encountering suspicious-looking areas on MRI.
Video Player is loading.
Video content above is prompted by the following questions:
- What are some of the key differences between organ-based tracking and probe tracking technologies used in the current fusion-guided platforms? How do these differences impact the procedural workflow or your approach to these procedures?
- How do fusion-guided and MRI-targeted biopsy options compare? What are some of the key differences between MRI/US fusion-guided elastic biopsy and MRI-targeted biopsy?
Related Videos
Dr Louise Kostos on the rapidly evolving prostate cancer treatment landscape
An expert’s view on combination ARPI/ADT and long-term toxicity in prostate cancer
Rana McKay, MD, on the role of radium-223 in the modern era
Dr Louise Kostos discusses PSA kinetics in mHSPC
Laura Bukavina, MD, on trial of radiation with concurrent sacituzumab govitecan in MIBC
The importance of PSADT in high-risk, biochemically recurrent prostate cancer
Neeraj Agarwal, MD, outlines data on enzalutamide plus talazoparib in mCRPC
Expert discusses triplet regimens in metastatic hormone-sensitive prostate cancer
Alicia Morgans, MD, MPH, on PSADT awareness and prostate cancer treatment initiation
Dr Louise Kostos discusses combination therapies in mHSPC
Related Content
